Interestingly, CD63 expression was shown here to be significantly pronounced and co-localized with angiogenic marker VEGF compared to glial marker GFAP or neurogenic marker MAP2, suggesting that the CD63-labeled extracellular vesicles preferably mediated host angiogenesis after stroke. The gene discussed is GFAP; the disease is stroke disorder.